(MedPage Today) — The first FDA-approved treatment option for Sjögren’s disease might be on the horizon, as neonatal Fc receptor (FcRn) blockers show promise in early data.
B-cell activation in Sjögren’s disease results in immunoglobulin…
After Hantavirus scare, Norovirus outbreak on another cruise ship sparks concern: How they differ from Covid-19, symptoms to know
After Hantavirus scare, Norovirus outbreak on another cruise ship sparks concern: How they differ from Covid-19, symptoms to know Source:...





